Biocon Secures ₹4,500 Crore for Global Biopharma Push India’s top biopharmaceutical firm, Biocon, has completed its first equity offering since going public. The funds will be used to support advanced research and development, reduce debt, and enhance access to affordable … Continue reading Biocon Secures ₹4,500 Crore for Global Biopharma Push